4 unknown, 3 completed, 2 recruiting. 2 Not applicable, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 1, Unknown 1 |
| Phase 2 | 2 | Unknown 2 |
Follow ctDNA analysis: new trials by email Literature Review of ctDNA analysis trials Research Report on ctDNA analysis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Predictive Biomarkers of Response to Checkpoint Inhibitors in Triple Negative Breast Cancer: a Multiomics Platform Whole Genome Sequencing, RNA-Sequencing, Microbiome analysis - Triple Negative Breast Cancer | Recruiting | Vall d'Hebron Institute of Oncology | 100 | 2023-01-13 | 2023-06-23 | |
| Circulating Tumor DNA as Surgical Biomarker in Patients With PancrEatic Adenocarcinoma for Statement of Resectability ctDNA analysis - PDAC - Pancreatic Ductal Adenocarcinoma | Not applicable | Unknown | Azienda Ospedaliera Universitaria Integrata Verona | 165 | 2022-12-29 | 2023-05-10 |
| The circTeloDIAG: Liquid Biopsy for Glioma Tumor ctDNA analysis - Glioma | Recruiting | Hospices Civils de Lyon | 150 | 2021-11-04 | 2023-10-11 | |
| Early Assessment of Response to Treatment of Metastatic LUng Tumors Based on CIrculating Tumor DNA ctDNA analysis - Metastatic Non-small Cell Lung Cancer | Not applicable | Completed | Centre Hospitalier Departemental Vendee | 100 | 2019-06-27 | 2025-12-04 |
| CAcTUS - Circulating Tumour DNA Guided Switch ctDNA analysis - Melanoma | Phase 2 | Unknown | The Christie NHS Foundation Trust | 21 | 2019-05-02 | 2023-08-25 |
| MEchanisms of Resistance in EGFR Mutated Nonpretreated Advanced Lung Cancer Receiving OSimErtib TAGRISSO® 80mg (Osimertinib), Tumor biopsies, ctDNA analysis - Non-small Cell Lung Cancer | Phase 2 | Unknown | Nantes University Hospital | 150 | 2019-04-09 | 2024-02-28 |
| ALK/ROS1/MET Mutations on Plasma ctDNA in Patients With NSCLC ctDNA analysis - Non-small Cell Lung Cancer Stage III, Non-Small-Cell Lung Cancer Metastatic | Unknown | First People's Hospital of Hangzhou | 200 | 2016-11-01 | 2016-10-27 | |
| EGFR Mutations on ctDNA in Patients With Advanced NSCLC mutation detection, ARMS, ctDNA analysis - Non-small Cell Lung Cancer Stage III, Non-Small-Cell Lung Cancer Metastatic | Completed | First People's Hospital of Hangzhou | 1055 | 2016-01-01 | 2018-02-13 | |
| T790M Mutation on ctDNA in Patients With NSCLC After EGFR-TKI Failure mutation detection, ARMS and ddPCR, ctDNA analysis - Non-small Cell Lung Cancer Stage III, Non-Small-Cell Lung Cancer Metastatic | Completed | First People's Hospital of Hangzhou | 314 | 2015-03-01 | 2018-03-12 |
Carcinoma, Non-Small-Cell Lung (5) · Adenocarcinoma of Lung (1) · Glioma (1) · Melanoma (1) · Recurrence (1) · Triple Negative Breast Neoplasms (1)
First People's Hospital of Hangzhou (3) · Azienda Ospedaliera Universitaria Integrata Verona (1) · Centre Hospitalier Departemental Vendee (1) · Hospices Civils de Lyon (1) · Nantes University Hospital (1) · The Christie NHS Foundation Trust (1) · Vall d'Hebron Institute of Oncology (1)
China (3) · France (3) · Italy (1) · Spain (1) · United Kingdom (1)
Paul Lorigan (1)